These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15698729)

  • 1. Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases.
    Yedibela S; Elad L; Wein A; Dimmler A; Merkel S; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2005 Mar; 31(2):141-6. PubMed ID: 15698729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis.
    Wiseman JT; Guzman-Pruneda F; Xourafas D; Chun YS; Ejaz A; Tsung A; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2019 Jul; 229(1):69-77.e2. PubMed ID: 30905856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases.
    Hatwell C; Bretagnol F; Farges O; Belghiti J; Panis Y
    Colorectal Dis; 2013 Jan; 15(1):e21-8. PubMed ID: 23088162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
    Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T
    Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
    Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
    Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
    Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma.
    Rivoire M; De Cian F; Meeus P; Négrier S; Sebban H; Kaemmerlen P
    Cancer; 2002 Dec; 95(11):2283-92. PubMed ID: 12436433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: "a note of caution".
    Pelegrina A; Martí J; Miquel R; Ferrer J; Hernández-Gea V; Diaz A; Nadal C; García-Valdecasas JC; Fuster J
    World J Surg Oncol; 2017 Dec; 15(1):224. PubMed ID: 29246174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer.
    Simpson AL; Leal JN; Pugalenthi A; Allen PJ; DeMatteo RP; Fong Y; Gönen M; Jarnagin WR; Kingham TP; Miga MI; Shia J; Weiser MR; D'Angelica MI
    J Am Coll Surg; 2015 Mar; 220(3):271-80. PubMed ID: 25617913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and Outcomes of Synchronous Resection of Colorectal Metastasis in the Modern Era-Analysis of Targeted Hepatic NSQIP Database.
    Jones TJ; Murphy AE; Tameron A; Hussain LR; Grannan K; Guend H; Dunki-Jacobs EM; Lee DY
    J Surg Res; 2019 Jun; 238():35-40. PubMed ID: 30735964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients.
    Benoist S; Salabert AS; Penna C; Karoui M; Julié C; Rougier P; Nordlinger B
    Surgery; 2006 Sep; 140(3):396-403. PubMed ID: 16934601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection for colorectal liver metastases in older patients.
    de Liguori Carino N; van Leeuwen BL; Ghaneh P; Wu A; Audisio RA; Poston GJ
    Crit Rev Oncol Hematol; 2008 Sep; 67(3):273-8. PubMed ID: 18595728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.
    Pandanaboyana S; White A; Pathak S; Hidalgo EL; Toogood G; Lodge JP; Prasad KR
    Ann Surg Oncol; 2015 Jan; 22(1):173-9. PubMed ID: 25084766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatectomy for Colorectal Cancer Liver Metastases in the Era of Modern Preoperative Chemotherapy: Evaluation of Postoperative Complications.
    Fukuoka K; Nara S; Honma Y; Kishi Y; Esaki M; Shimada K
    World J Surg; 2017 Apr; 41(4):1073-1081. PubMed ID: 27679508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The safety and efficacy of neoadjuvant chemotherapy for patients with hepatic colorectal cancer metastases].
    Miyamoto A; Nakamori S; Tsujie M; Kurokawa Y; Yasui M; Ikenaga M; Miyazaki M; Hirao M; Fujitani K; Mishima H; Tsujinaka T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2022-4. PubMed ID: 20037311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.
    Kesmodel SB; Ellis LM; Lin E; Chang GJ; Abdalla EK; Kopetz S; Vauthey JN; Rodriguez-Bigas MA; Curley SA; Feig BW
    J Clin Oncol; 2008 Nov; 26(32):5254-60. PubMed ID: 18854565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
    Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
    J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation.
    van Amerongen MJ; van der Stok EP; Fütterer JJ; Jenniskens SF; Moelker A; Grünhagen DJ; Verhoef C; de Wilt JH
    Eur J Surg Oncol; 2016 Apr; 42(4):523-30. PubMed ID: 26856957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.